Latest Articles
Integrative single-cell analysis reveals Bu-Shen-Huo-Xue Formula rescues iron-overloaded ovarian function via rewiring IFN-γ/JAK/STAT/CXCL10-driven immune-stromal interactions and BNIP3-mediated mitophagy in endometriosis.
Ovarian endometriosis (OE) is a leading cause of female infertility. Our previous work identified iron overload-driven oxidative stress and mitochondrial dysfunction in granulosa cells as key pathogenic features, yet the …
Published: May 23, 2026, midnight
Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD - Contemporary OB/GYN
Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD Contemporary OB/GYN
Published: May 22, 2026, 5:16 p.m.
Endometrial Serous Carcinoma Arising From Adenomyosis - Cureus
Endometrial Serous Carcinoma Arising From Adenomyosis Cureus
Published: May 22, 2026, 4:43 p.m.
5 Conditions Endometriosis Is Commonly Mistaken For—and Why Getting It Right Matters - AJMC
5 Conditions Endometriosis Is Commonly Mistaken For—and Why Getting It Right Matters AJMC
Published: May 22, 2026, 4:36 p.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times
Published: May 22, 2026, 4:14 p.m.
I went to A&E four times before being diagnosed with endometriosis – I nearly died - MSN
I went to A&E four times before being diagnosed with endometriosis – I nearly died MSN
Published: May 22, 2026, 12:43 p.m.
Could the secret to diagnosing endometriosis be hiding in plain sight? - National Geographic
Could the secret to diagnosing endometriosis be hiding in plain sight? National Geographic
Published: May 22, 2026, 11:03 a.m.
Hinduja Hospital Launches Endometriosis Clinic in Mumbai - Voice of Healthcare
Hinduja Hospital Launches Endometriosis Clinic in Mumbai Voice of Healthcare
Published: May 22, 2026, 8:40 a.m.
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times
Published: May 22, 2026, 4:29 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
Link copied to clipboard!